Home » Topics » Regulatory

Regulatory
RSS

Positive E.U. opinion for Pegasys combination therapy in HIV-HCV patients

Dec. 22, 2004

Macugen approved for neovascular AMD

Dec. 21, 2004

Fast track designation for Remicade for ulcerative colitis

Dec. 21, 2004

FDA approval for Kepivance

Dec. 20, 2004

Zylet receives FDA approval

Dec. 17, 2004

Lunesta approved for treatment of insomnia

Dec. 17, 2004

Equetro approved for bipolar disorder

Dec. 15, 2004

Tumor necrosis factor inhibitor may attenuate postmyocardial infarction ventricular remodeling

Dec. 3, 2004

Diovan approved in Sweden to treat high-risk heart attack patients

Dec. 3, 2004

Atacand approved in Europe for treatment of chronic heart failure

Nov. 30, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...